Rethinking heart failure care and health technologies from early COVID-19 experiences - A narrative review

Satici, Sakine; Iyngkaran, Pupalan; Andrew, Sharon; Patil, Arun; Bidargaddi, Niranjan; Battersby, Malcolm; Courten, Maximilian de

doi:10.31083/j.rcm.2021.01.272

Cited by 5 publications

(4 citation statements)

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Table 2 Potential benefits of virtual follow-up visits of patients with HF using the protocol devised Notwithstanding these limitations, it is clear that health technology solutions are needed to improve on gaps in care. 19 Implementation of a priority system and telemedicine are now being actively discussed, and it is certain that telemedicine will play an increasing role in the future, even in the post-COVID-19 era. 20…”

Section: Discussionmentioning

confidence: 99%

LEAP Virtual Visit Assessment (VIVA): a structured protocol for virtual visits for patients with heart failure

Gori

Bonmassari

Correale

et al. 2022

Journal of Cardiovascular Medicine

View full text Add to dashboard Cite

Aims Telemedicine may be of benefit in patients with heart failure (HF), although virtual visits are often carried out on an ad hoc basis. Herein, we discuss a structured protocol that defines all the steps needed for virtual visits, LEAP Virtual Visit, which includes guides and support kits for clinicians and patients.Methods A working group of clinicians was established to develop a protocol for virtual visits. The virtual model for monitoring HF patients was based on measurement and sizing of patient flows, type of services, and critical organizational points. The process of virtual visits was broken down to identify the specific activities, players, roles, and support tools needed for implementation in daily practice. ResultsIn the protocol developed, sections were included on patient eligibility, exams, supportive tools, and practical organizational aspects. IT requirements were also considered and the most widely used teleconference platforms were compared according to features that were considered to be priority for virtual visits. Protocols and support kits were developed, including guides for clinicians and patients, two questionnaires to assess the level of satisfaction, patient diary, disease awareness brochure, and template to monitor key performance indicators. The phases include an enrolment phase, document sharing phase, pre-evaluation phase, the virtual visit itself, and the post-visit phase. The protocol for the virtual visit was divided into 8 sequential steps to be carried out between the clinic and patient/caregiver. ConclusionThe protocol described can be expected to have a number of benefits for the patient, clinic, and healthcare structure.

show abstract

Section: Discussionmentioning

confidence: 99%

LEAP Virtual Visit Assessment (VIVA): a structured protocol for virtual visits for patients with heart failure

Gori

Bonmassari

Correale

et al. 2022

Journal of Cardiovascular Medicine

View full text Add to dashboard Cite

show abstract

“…D-Heart® is a portable device that enables the acquisition of the ECG on multiple leads, which is then streamed via Bluetooth to any smartphone [76]. Despite these opportunities, the impact of mHealth interventions on cardiovascular mortality, HF hospitalizations, NYHA class, quality of life and LVEF are inconsistent; however, further research is necessary, and these results should be contextualized during the pandemic [77].…”

Section: The Importance Of Telemedicine In the 21st Century And The Covid Eramentioning

confidence: 99%

The relevance of specific heart failure outpatient programs in the COVID era: an appropriate model for every disease

Beltrami¹,

Bartolini²,

Milli³

et al. 2021

Rev. Cardiovasc. Med.

View full text Add to dashboard Cite

Heart Failure (HF) is characterized by an elevated readmission rate, with almost 50% of events occurring after the first episode over the first 6 months of the post-discharge period. In this context, the vulnerable phase represents the period when patients elapse from a sub-acute to a more stabilized chronic phase. The lack of an accurate approach for each HF subtype is probably the main cause of the inconclusive data in reducing the trend of recurrent hospitalizations. Most care programs are based on the main diagnosis and the HF stages, but a model focused on the specific HF etiology is lacking. The HF clinic route based on the HF etiology and the underlying diseases responsible for HF could become an interesting approach, compared with the traditional programs, mainly based on non-specific HF subtypes and New York Heart Association class, rather than on detailed etiologic and epidemiological data. This type of care may reduce the 30-day readmission rates for HF, increase the use of evidence-based therapies, prevent the exacerbation of each comorbidity, improve patient compliance, and decrease the use of resources. For all these reasons, we propose a dedicated outpatient HF program with a daily practice scenario that could improve the early identification of symptom progression and the quality-of-life evaluation, facilitate the access to diagnostic and laboratory tools and improve the utilization of financial resources, together with optimal medical titration and management.

show abstract

“…The scope includes safeguarding privacy, sharing information, funding models, and selecting outcome measures for efficacy trials. The latter emphasizes cost-effectiveness, aiding the clinical translation of findings [ 1 - 3 ].…”

Section: Introductionmentioning

confidence: 99%

“…However, medical services and information have different sensitivities than liberal rules with social uses. This means the boundaries of doctor-patient encounters, factoring, and technology have never seen a satisfactory solution to allow the full breadth of technological achievements to prosper [ 1 - 4 ]. Among its greatest strengths is bridging Malthusian concepts of resourcing and population growth.…”

Section: Introductionmentioning

confidence: 99%

Malthusian Trajectory for Heart Failure and Novel Translational Ambulatory Technologies

Bidagarddi

Iyngkaran

et al. 2023

CCR

Self Cite

View full text Add to dashboard Cite

Introduction: Congestive heart failure (CHF) will reach epidemic proportions and contribute to large unsustainable impacts on health budgets for any single cardiovascular condition. Against other major cardiovascular outcomes trends, readmission and disease burden continue to rise as the demographics shift. Methods: The rise of heart failure with preserved ejection fraction (HFpEF) among elderly women will present new challenges. Gold standard care delivers sustainable and cost-effective health improvements using organised programs of care. When coordinated from large hospitals, this can be replicated universally. Mini review and perspective. Result: A gradient of outcomes with ambulatory care when greater care is relegated away from established institutions and shared with clients and community health services. This is now a sizeable proportion of CHF care. Conclusion: In this review, we explore health technologies as an emerging opportunity to confront and address this gap in CHF management.

show abstract

Rethinking heart failure care and health technologies from early COVID-19 experiences - A narrative review

Cited by 5 publications

References 67 publications

LEAP Virtual Visit Assessment (VIVA): a structured protocol for virtual visits for patients with heart failure

LEAP Virtual Visit Assessment (VIVA): a structured protocol for virtual visits for patients with heart failure

The relevance of specific heart failure outpatient programs in the COVID era: an appropriate model for every disease

Malthusian Trajectory for Heart Failure and Novel Translational Ambulatory Technologies

Contact Info

Product

Resources

About